CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2026-05-20 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2024-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +47,500 | 47,500 | ||
| 2024-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +47,500 | 47,500 | ||
| 2024-04-19 | BAKER BROS. ADVISORS LP Director | Purchase · Warrants to purchase Common Stock | +825,968 | $7.13 | $5.9M | 4,018,678 |
| 2024-04-19 | BAKER BROS. ADVISORS LP Director | Purchase · Warrants to purchase Common Stock | +8,851,451 | $7.13 | $63.1M | 43,158,741 |
| 2023-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +3,192,710 | $2.00 | $6.4M | 3,192,710 |
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +34,307,290 | $2.00 | $68.6M | 34,307,290 |
| 2022-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +9,146 | 9,146 | ||
| 2022-05-11 | BAKER BROS. ADVISORS LP Director | Purchase | +2,882 | $1.99 | $6K | 256,209 |
| 2022-05-11 | BAKER BROS. ADVISORS LP Director | Purchase | +22,983 | $1.99 | $46K | 2,528,583 |
| 2022-05-10 | BAKER BROS. ADVISORS LP Director | Purchase | +40,800 | $1.70 | $69K | 145,498 |
| 2022-05-10 | BAKER BROS. ADVISORS LP Director | Purchase | +325,373 | $1.70 | $553K | 1,645,675 |
| 2022-05-10 | BAKER BROS. ADVISORS LP Director | Purchase | +12,769 | $1.93 | $25K | 158,267 |
| 2022-05-10 | BAKER BROS. ADVISORS LP Director | Purchase | +101,831 | $1.93 | $197K | 1,747,506 |
| 2022-05-10 | BAKER BROS. ADVISORS LP Director | Purchase | +95,060 | $1.95 | $185K | 253,327 |
Page 1 of 2 · 27 trades